• If this is your first visit, be sure to check out the FAQ & read the forum rules. To view all forums, post or create a new thread, you must be an AAPC Member. If you are a member and have already registered for member area and forum access, you can log in by clicking here. If you've forgotten the password it can be reset on our sign in section by entering your registered Email Address or Username here. To start viewing messages, select the forum that you want to visit from the selection below..

Prolia-LCD Policy Medical Necessity and Osteoporosis

Slbishop

New
Messages
2
Location
Shelton, CT
Hello all,
Would anyone be able to help clarify the LCD policy for Prolia (J0897) Injection for Osteoporosis? I was told we needed an additional diagnosis besides having Osteoporosis, usually the patient cannot take oral Bisphosphonates, which would fall under Group 3 and/or 4 which does require 2 diagnosis, Osteoporosis and the reason for using Prolia. However If the physicians's order just states M81.0 Osteoporosis, can we accept that diagnosis alone, under Group 2? Groups 2 states, Treatment of Osteoporosis at High Risk for Fracture? Any assistance in this would be greatly appreciated. Thank you!
 
I assume you are referencing the NGS LCA A52399 for Denosumab. That's what came up when I filtered for Connecticut anyway :) Based on what I'm reading, M81.0 only is perfectly acceptable for patients at high-risk. We regularly report only M81.0 without problem. You only need a secondary or tertiary diagnosis in certain circumstances.
 
Thank you! That's the way I was reading the policy. Yes it is-LCA-A52399. But I was told I need that 2nd DX, for any Prolia Patients.
Thanks again for your input.
 
Top